SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-08-109817
Filing Date
2008-05-09
Accepted
2008-05-09 16:23:01
Documents
5
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 662853
2 AMENDED AND RESTATED DIRECTOR COMPENSATION POLICY dex102.htm EX-10.2 12592
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 8818
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 8897
5 SECTION 906 CEO AND CFO CERTIFICATION dex32.htm EX-32 4270
  Complete submission text file 0001193125-08-109817.txt   698932
Mailing Address 134 COOLIDGE AVE WATERTOWN MA 02472
Business Address 134 COOLIDGE AVE WATERTOWN MA 02472 617-926-1551
PANACOS PHARMACEUTICALS, INC. (Filer) CIK: 0001040017 (see all company filings)

IRS No.: 113238476 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24241 | Film No.: 08818740
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1